Sign in
CompletedNo phase

Volume Resuscitation in Cirrhosis With Sepsis Induced Hypotension

Key facts

Who runs it
Post Graduate Institute of Medical Education and Research, Chandigarh
Where
India2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
350 people enrolled
Started
1 Feb 2020
Ended
10 Aug 2025
Type of study
Observational
Treatments tested
  • Albumin + electrolyte solution
  • POCUS guided fluid resuscitation
Record updated
2 September 2025

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (15)Hide the full registry criteria

Who can take part

  • Clinical/Imaging or Biopsy proven liver cirrhosis of any etiology
  • Hypotension (MAP <65mmHg or SBP <90mmHg)
  • 18-65 yrs of age

Who cannot take part

  • Already received colloid or 2 litres of fluid within the first 2 hours of presentation, without echocardiographic assessment
  • Severe pre-existing cardiopulmonary disease
  • Acute Respiratory Distress Syndrome (ARDS)
  • Active bleeding like variceal bleed 28
  • Chronic renal disease - End Stage Renal Disease (ESRD)/ patient on renal replacement therapy
  • Admission to ICU following liver transplantation, burns, cardiac surgery
  • Previous adverse reaction to human albumin solution
  • Already on vasopressors/inotropes
  • Cerebrovascular events
  • Brain death or likely brain death within 24 hours
  • Pregnant or lactating women
  • Informed consent refused by patient or attendants

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

In critically ill patients with liver disease like cirrhosis or ACLF, fluid therapy needs to be instituted after identification of patients who will be fluid responsive and initiate appropriate inotropes early to prevent the mortality associated with fluid overload.

Read full original descriptionShow less

The parameters and methodology used for assessing fluid responsiveness have been studied earlier, but the optimum method is not established. Existing recommendations based on data regarding fluid responsiveness and choice of fluid for resuscitation from intensive care units in general cannot be applied to those with liver disease as the hemodynamic alterations that occur with liver disease, presence of hypoalbuminemia at baseline and presence of cardiac dysfunction interfere with the conventional methods of fluid status assessment, fluid responsiveness as well as the response to different types of resuscitation fluids.

Therefore the investigators attempt to compare various methods to estimate current intravascular volume status of patient which could be helpful in guiding fluid therapy.

The group in the trial

  • Cirrhosis/ACLF of any etiology

    Treatment: Albumin + electrolyte solution and POCUS guided fluid resuscitation

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
To Compare the Effectiveness of Various Methods of Estimating Volume Resuscitation in Patients With Cirrhosis With Sepsis Induced Hypotension
Record updated
2 September 2025